Clinical Trial Update: Superiority of MACI® Versus Microfracture Treatment in Patients With Symptomatic Articular Cartilage Defects in the Knee [Phase 3]

View source ↗

Summary

Phase 3 trial showing superiority of MACI (autologous matrix-induced chondrogenesis) versus microfracture for symptomatic articular cartilage defects of the kne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Defect of the Knee

Drugs mentioned

• MACI (matrix-induced autologous chondrocyte implantation)

Snippet

Sponsor: Vericel Corporation | Conditions: Articular Cartilage Defect | Phase 3 | Status: COMPLETED | Results posted: 2017-12-14